EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Effectiveness of Recombinant Human Bone Morphogenetic Protein‐2 in Socket Preservation: A Randomized Controlled Clinical and Sequential Human Histological Trial (BMP‐2 TRIAL)

Saravanan Sampoornam Pape Reddy iD, Delfin Lovelina Francis iD, Harshini Thirumoorthi iD, Rahul iD, Manish Rathi iD, Harjeet Singh iD, Shaswata Karmakar iD, Shaili Pradhan iD

Clinical and Experimental Dental Research · 2025

DOI: 10.1002/cre2.70134 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Clinical and Experimental Dental Research, 2025. Verfasst von Saravanan Sampoornam Pape Reddy und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Army Dental Centre (Research & Referral), New Delhi, India. Hauptthemen laut MEDLINE: Bone Morphogenetic Protein 2, Tooth Socket, Transforming Growth Factor beta, Hydroxyapatites. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The aim of this study was to evaluate the effectiveness of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) coated biphasic calcium phosphate (BCP) in socket preservation in comparison to BCP. Material and Methods Patients who underwent extraction of maxillary premolars were randomized to receive rhBMP‐2/BCP ( n = 15) and BCP alone ( n = 15). All sites were primarily closed using a pedicled connective tissue flap. Biopsy was carried out in patients at 3 ( n = 10), 6 ( n = 10), and 9 ( n = 10) months.

Results

At 3 months, BMP and non‐BMP groups had 3.17% and 3.12% new bone formation, respectively, and 3.8% and 37.85% of residual grafts, respectively, and 25.86% and 25.99% connective tissue component, respectively. At 6 months, both groups revealed 67.42% and 16.55% essential bone growth, 1.74% and 3.04% of residual graft, and 1.3% and 67% connective tissue component, respectively. At 9 months, the BMP group revealed 93.6% new bone formation, 0.68% residual graft, and 1.9% connective tissue component, while the non‐BMP groups had 23.35% new bone formation, 4.45% residual graft, and 44.06% connective tissue component.

Conclusion

This study demonstrated that rhBMP‐2 coated BCP significantly enhanced early graft substitution in socket preservation sites compared to BCP alone. There was a significantly higher percentage of new bone formation in the rhBMP‐2/BCP group both at 6 and 9 months. Additionally, the rhBMP‐2/BCP group exhibited faster resorption of the graft material and earlier maturation of newly formed bone. These findings strongly suggest that rhBMP‐2/BCP can be an effective treatment modality for socket preservation, promoting predictable and accelerated bone regeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone Morphogenetic Protein 2Tooth SocketTransforming Growth Factor betaHydroxyapatitesHumansRecombinant ProteinsMaleFemaleTooth ExtractionAdultMiddle AgedTreatment OutcomeOsteogenesisBone SubstitutesBicuspid

Stichwörter der Autor:innen

bone morphogenetic protein 2bone regenerationhistological techniqueregenerationridge augmentation

Substanzen

Bone Morphogenetic Protein 2Recombinant Proteinsrecombinant human bone morphogenetic protein-2Transforming Growth Factor betaHydroxyapatiteshydroxyapatite-beta tricalcium phosphateBone Substitutes

Autor:innen und Institutionen

  • Department of Periodontology, Army Dental Centre (Research & Referral), New Delhi, India.
  • Saveetha Dental College & Hospitals, Saveetha University, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, Tamil Nadu, India.
  • Arunai Medical College & Hospital, Tiruvannamalai, Tamil Nadu, India.
  • 3 Corps Dental Unit, Army Dental Corps, Indian Army, India.
  • Department of Periodontology, Manipal College of Dental Sciences, Manipal Academy of Higher Education, Manipal, India.
  • Department of Periodontology & Oral Implantology, Kathmandu Medical College Public Limited, Kathmandu, Bagmati, Nepal.

ORCID-Profile: Saravanan Sampoornam Pape Reddy, Delfin Lovelina Francis, Harshini Thirumoorthi, Rahul, Manish Rathi, Harjeet Singh, Shaswata Karmakar, Shaili Pradhan

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Reddy, S. S. P., Francis, D. L., Thirumoorthi, H., Rahul, Rathi, M., Singh, H., Karmakar, S., & Pradhan, S. (2025). Effectiveness of Recombinant Human Bone Morphogenetic Protein‐2 in Socket Preservation: A Randomized Controlled Clinical and Sequential Human Histological Trial (BMP‐2 TRIAL). Clinical and Experimental Dental Research. https://doi.org/10.1002/cre2.70134

Vancouver

Reddy SSP, Francis DL, Thirumoorthi H, Rahul, Rathi M, Singh H, et al. Effectiveness of Recombinant Human Bone Morphogenetic Protein‐2 in Socket Preservation: A Randomized Controlled Clinical and Sequential Human Histological Trial (BMP‐2 TRIAL). Clinical and Experimental Dental Research. 2025. doi:10.1002/cre2.70134

BibTeX
@article{Reddy2025,
  author = {Reddy, Saravanan Sampoornam Pape and Francis, Delfin Lovelina and Thirumoorthi, Harshini and Rahul and Rathi, Manish and Singh, Harjeet and Karmakar, Shaswata and Pradhan, Shaili},
  title = {Effectiveness of Recombinant Human Bone Morphogenetic Protein‐2 in Socket Preservation: A Randomized Controlled Clinical and Sequential Human Histological Trial (BMP‐2 TRIAL)},
  journal = {Clinical and Experimental Dental Research},
  year = {2025},
  doi = {10.1002/cre2.70134}
}
Kostenlos starten →